Parkinson hastalığında dil becerileri: sanatın durumu.
Language skills in Parkinson's disease: state of the art.
DOI: 10.1590/1980-5764-dn-2025-0350PMID: 41668839
Language skills in Parkinson's disease: state of the art.
DOI: 10.1590/1980-5764-dn-2025-0350PMID: 41668839
Predictive factors of global cognitive impairment in de novo Parkinson disease with normal cognition at baseline: a 10-year cohort study.
DOI: 10.1007/s10072-026-08865-0PMID: 41644752
The efficacy and safety of high-frequency SMA-rTMS on freezing of gait in patients with Parkinson's disease: a study protocol for a randomized controlled trial.
DOI: 10.1186/s12906-026-05254-0PMID: 41645156
Correction Paschou et al., Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson's disease iPSC model.
DOI: 10.1073/pnas.2601834123PMID: 41650245
On the Suitability of Data Augmentation Techniques to Improve Parkinson's Disease Detection with Speech Recordings.
DOI: 10.3390/diagnostics16030498PMID: 41681817
Taurine modulates gut microbiota and attenuates inflammation in a rotenone-induced mouse model of Parkinson's disease.
DOI: 10.1016/j.neuro.2026.103401PMID: 41655711
TRPV2 protects dopaminergic neurons via ferroptosis inhibition in Parkinson's disease.
DOI: 10.1016/j.lfs.2026.124257PMID: 41655782
Frankincense improves motor symptoms and attenuates the progression of Paraquat (PQ)-induced Parkinson's disease in mice by attenuating oxidative stress, inflammation, and apoptotic cell death and improving nerve growth factor gene expression.
DOI: 10.1016/j.ibneur.2026.02.008PMID: 41716729
Current potential biomarkers for Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: review of literature.
DOI: 10.1080/19585969.2026.2622722PMID: 41646005
Optimized cortical EEG modeling for Parkinson disease diagnosis with snow Shepherd Stride tuning mechanism.
DOI: 10.1007/s11571-025-10406-yPMID: 41657964
<span class="word">Repurposing <span class="word"><span class="changedDisabled">Antidiabetic <span class="word"><span class="changedDisabled">Medications <span class="word">for <span class="word">Parkinson’s <span class="word"><span class="changedDisabled">Disease: <span class="word"><span class="changedDisabled">Focus <span class="word">on <span class="word"><span class="changedDisabled">Biomarker <span class="word"><span class="changedDisabled">Strategies <span class="word">on <span class="word"><span class="changedDisabled">Disease <span class="word"><span class="changedDisabled">Modification
DOI: 10.20944/preprints202602.0422.v1
Patient-reported Vision Quality-of-life in Parkinsonian Syndromes and Ataxias and Association with Clinical Oculomotor Findings
DOI: 10.64898/2026.02.03.26345521
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.